Zobrazeno 1 - 10
of 4 454
pro vyhledávání: '"ROS1"'
Autor:
Urska Janzic, Natalie Maimon Rabinovich, Walid Shalata, Waleed Kian, Katarzyna Szymczak, Rafal Dziadziuszko, Marko Jakopovic, Giannis Mountzios, Adam Pluzanski, Antonio Araujo, Andriani Charpidou, Sameh Daher, Abed Agbarya
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4369-4381 (2024)
ROS1 rearrangements are considered rare in non-small-cell lung cancer (NSCLC). This retrospective real-world study aimed to evaluate first-line treatment with crizotinib, a tyrosine kinase inhibitor (TKI) standard of care vs. new generation ROS1 anti
Externí odkaz:
https://doaj.org/article/adb21f604fcc4328811acd70c304e952
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 781-789 (2024)
Alvaro Osorio,1,2 Liliana Fernandez-Trujillo,2,3 Juan G Restrepo,1,2 Luz F Sua,2,4 Catalina Proaño,5 Valeria Zuñiga-Restrepo2 1Department of Internal Medicine, Oncology Service, Fundación Valle Del Lili, Cali, Colombia; 2Faculty of Health Sciences
Externí odkaz:
https://doaj.org/article/92ad0eda539f40b6a530324f2e803abc
Autor:
Anjali Murali, Anju Farsana A, Sobha Subramaniam, Malini Eapen, Indu R. Nair, Keechilat Pavithran
Publikováno v:
Respirology Case Reports, Vol 12, Iss 9, Pp n/a-n/a (2024)
Abstract Non‐small‐cell lung cancer (NSCLC) accounts for the majority of lung cancer cases worldwide, with a significant proportion of patients harbouring actionable oncogenic alterations. Among these alterations, the ROS1 rearrangement represent
Externí odkaz:
https://doaj.org/article/e576f169d0914bc996d0df38edd7efcd
Autor:
Ariel R. Choi, Ralph B. D’Agostino, Michael K. Farris, Mohammed Abdulhaleem, John C. Hunting, Yuezhu Wang, Margaret R. Smith, Jimmy Ruiz, Thomas W. Lycan, W. Jeffrey Petty, Christina K. Cramer, Stephen B. Tatter, Adrian W. Laxton, Jaclyn J. White, Wencheng Li, Jing Su, Christopher Whitlow, Fei Xing, Michael D. Chan
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Purpose/objective(s)Biomarkers for extracranial oligometastatic disease remain elusive and few studies have attempted to correlate genomic data to the presence of true oligometastatic disease.MethodsPatients with non-small cell lung cancer (NSCLC) an
Externí odkaz:
https://doaj.org/article/6364785a593e426591cfe97e0776e128
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-5 (2024)
Externí odkaz:
https://doaj.org/article/99adb6ee4377419d9ad4b8250b90bb2b
Autor:
Marc Terrones, Christophe Deben, Felicia Rodrigues-Fortes, Anne Schepers, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Introduction The study of resistance-causing mutations in oncogene-driven tumors is fundamental to guide clinical decisions. Several point mutations affecting the ROS1 kinase domain have been identified in the clinical setting, but their imp
Externí odkaz:
https://doaj.org/article/8badfa4b346b46089af6735007b9b043
Autor:
Maged Daruish, Francesca Ambrogio, Anna Colagrande, Andrea Marzullo, Rita Alaggio, Irma Trilli, Giuseppe Ingravallo, Gerardo Cazzato
Publikováno v:
Dermatopathology, Vol 11, Iss 1, Pp 112-123 (2024)
In recent years, particular interest has developed in molecular biology applied to the field of dermatopathology, with a focus on nevi of the Spitz spectrum. From 2014 onwards, an increasing number of papers have been published to classify, stratify,
Externí odkaz:
https://doaj.org/article/d2e0a368607240e2ac9250a83b7571fc
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 7, Pp 100673- (2024)
Repotrectinib, licensed in November 2023, is a novel ROS1 tyrosine kinase inhibitor (TKI) with activity against G2032R, the most common resistance mutation to prior generations of ROS1 TKIs. Here, we report a case of a patient who was heavily pretrea
Externí odkaz:
https://doaj.org/article/7431ea6377e4481c94bd50a8012202bb